It was agreed that the Blood Donor Program must continue to operate at its present level (300,000 bleedings per month) and that plasma processing facilities be used without interruption.
The study mainly include the aggregation behavior of hemicyanine derivatives in LB films, the influence of the donor acceptor on the excited level and excited lifetime of the hemicyenine derivatives.